AI shows the same accuracy as a cardiologist in detecting rheumatic heart disease

Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD) with the same accuracy as a cardiologist, according to new research demonstrating how sophisticated deep learning technology can be applied to this disease of inequity.

Psych Capital Changes Name To Shortwave Life Sciences | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – June 7, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland”), a company engaged in

June 11, 2024

AstraZeneca and Cellectis partner to advance cell and gene therapies – Pharmaceutical Technology

Cellectis will also be in line to receive an IND option fee and milestone-based payments of about $70m-$220m for each of the ten candidates, along

November 1, 2023

Psychedelic Bulletin #142: Terran’s IP Portfolio; AMA Advocates Against Non-Medical Psychedelics; Couple Receives First Psilocybin Services in Oregon; Mass. Ballot Measure Ramps Up; NIDA and NIMH Directors Opine – Psychedelic Alpha

The Directors of the National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH)—billion dollar government research agencies—shared their thoughts on the

July 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.